The Peptide Advantage

Peptides represent a powerful approach to drug discovery and development.
Secreted peptides are of primary interest as drugs because they mediate important physiological effects in both health and disease. Peptides are the most direct route for exploiting genomic and proteomic discoveries for the treatment of disease and the creation of important new medicines.

Peptide-based drugs have shorter and more predictable development cycles.
With peptides, a lead candidate can be identified in months rather than years, as the desired biological activity is inherent in the molecule. Being native biomolecules, peptides are less likely to present toxicity or immunogenicity issues.

Peptides offer patent exclusivity.
Native peptides are good starting points for new product development, because they generally offer full freedom-to-operate. Once modified, they are new chemical entities, and thus afford excellent exclusivity owing to patent protection of the novel molecule and the methods used to generate them.

Peptides are a relatively unexplored class of potential drugs.
Despite the overwhelming advances in healthcare science and discovery, and a 20-fold increase in R&D spending since 1980, the pharmaceutical industry has produced a dwindling number of applications for approval of truly innovative drug candidates. This represents great untapped potential for new approaches.